ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

Latest financial news

Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018

Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018

Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference

Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference

Celyad Announces Third Quarter 2017 Business Update

Celyad Announces Third Quarter 2017 Business Update

Discover all financial news

Investor's kit

Annual Report 2016

Annual Report 2016

Celyad interim financial report H1 2017

Celyad interim financial report H1 2017

Celyad's corporate presentation

Celyad's corporate presentation

Financial Calendar

May 17, 2018

Q1 Business update 2018

August 28, 2018

Half year results 2018

Want to see more?

Know more about our regulated information